Alembic Pharmaceuticals Limited — Others, 02-07-2025: Copy of Newspaper Publication

Alembic Pharmaceuticals has announced the reported loss of 600 equity shares held by shareholder Subhashchandra Wamanrao Korpe. An application for issuance of duplicate share certificates has been filed. The company warns the public against dealing with these shares and invites any claims with supporting documents within 15 days. If no claims are received, duplicate certificates will be issued, and the company will not entertain any claims on the original certificates thereafter. This update ensures clear shareholder records and protects investors from unauthorized transactions.